Readily available treatment could help prevent heart disease in kidney patients

The estimated 19 million Americans living with chronic kidney disease (CKD) face a high risk of death from cardiovascular disease, usually related to high levels of blood phosphate. Now researchers at the School of Medicine have demonstrated that high blood phosphate directly stimulates calcification of blood vessels and that phosphate-binding drugs can decrease vascular calcification.

Washington University in St. Louis and AstraZeneca announce Alzheimer’s research collaboration

The School of Medicine and the pharmaceutical company AstraZeneca (NYSE:AZN) have announced a research collaboration that aims to develop new and improved ways to diagnose and treat Alzheimer’s disease. The major focus of the alliance will be biomarkers, characteristic changes in the brain and spinal fluid that physicians can use to diagnose Alzheimer’s disease and track its response to treatment.

‘Put on a happy face’

Courtesy Photo”Bye Bye Birdie,” the spring musical production by School of Medicine students, will be held April 24, 25 and 26 at the Whelpley Auditorium on the St Louis College of Pharmacy campus.

Psychiatric expert advocates tolerance and diversity

Co-author of Come On People: On the Path from Victims to Victors, Alvin Poussaint, will present the annual Martin Luther King Jr. Memorial lecture for the Assembly Series. The talk will be held at 4 p.m., on Tuesday, April 15 in the Laboratory Sciences Auditorium. Poussaint co-wrote Come on People with activist comedian Bill Cosby […]

Poussaint to speak on tolerance and diversity

An expert on race relations, prejudice and diversity issues in a multicultural society, Alvin Poussaint, M.D., will present the annual Martin Luther King Jr. Memorial Lecture for the Assembly Series. The talk will be held at 4 p.m., Tuesday, April 15, in the Laboratory Sciences Auditorium on the campus of Washington University in St. Louis.
View More Stories